These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26375702)

  • 1. [Lowering of blood pressure - by treatment of other risk factors].
    Souček M
    Vnitr Lek; 2015; 61(7-8):717-20. PubMed ID: 26375702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
    Vrablík M; Chmelík Z; Lánská V
    Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children.
    Casavalle PL; Lifshitz F; Romano LS; Pandolfo M; Caamaño A; Boyer PM; Rodríguez PN; Friedman SM
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):213-23. PubMed ID: 25581987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for development of diabetes mellitus, hypertension and dyslipidemia.
    Fukui M; Tanaka M; Toda H; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Imai S; Nakamura N
    Diabetes Res Clin Pract; 2011 Oct; 94(1):e15-8. PubMed ID: 21802759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swiss Hypertension and Risk Factor Program (SHARP): cardiovascular risk factors management in patients with type 2 diabetes in Switzerland.
    Pechère-Bertschi A; Greminger P; Hess L; Philippe J; Ferrari P
    Blood Press; 2005; 14(6):337-44. PubMed ID: 16403687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Components of metabolic syndrome and prognosis of renal cell cancer.
    Eskelinen TJ; Kotsar A; Tammela TLJ; Murtola TJ
    Scand J Urol; 2017 Dec; 51(6):435-441. PubMed ID: 28743221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects.
    Anari R; Amani R; Latifi SM; Veissi M; Shahbazian H
    Diabetes Metab Syndr; 2017; 11(1):37-41. PubMed ID: 27477531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia.
    Shmulewitz D; Auerbach SB; Lehner T; Blundell ML; Winick JD; Youngman LD; Skilling V; Heath SC; Ott J; Stoffel M; Breslow JL; Friedman JM
    Hum Hered; 2001; 51(1-2):8-19. PubMed ID: 11096265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease risks of childhood obesity in China.
    Li YP; Yang XG; Zhai FY; Piao JH; Zhao WH; Zhang J; Ma GS
    Biomed Environ Sci; 2005 Dec; 18(6):401-10. PubMed ID: 16544522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM; Candrilli SD; Kanyongo G
    Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of obesity with glucose, blood pressure, and lipid goals attainment in patients with concomitant diabetes and hypertension.
    Li P; Chen K; Nie Y; Guo LL; Wang HB; Wang SS; Wang AP; Hu DY; Mu YM; Li JH;
    Curr Med Res Opin; 2015; 31(9):1623-31. PubMed ID: 26051230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?
    Castillo-Sánchez M; Fàbregas-Escurriola M; Bergè-Baquero D; Fernández-SanMartín M; Goday-Arno A
    Clin Exp Hypertens; 2017; 39(5):441-447. PubMed ID: 28590147
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.